IL6 and obesity due to melanocortin 4 receptor deficiency: ENOblock treatment inhibited gluconeogenesis, adiposity and obesity-related inflammation via concomitant repression of the regulatory genes Pck-1, Srebp-1a and Srebp-1c, and Tnf-a and Il-6.